The Study on the Evaluation of Acupuncture Therapy on Primary Insomnia
- Conditions
- Primary Insomnia
- Interventions
- Other: the acupuncture groupOther: the placebo acupuncture group
- Registration Number
- NCT05830877
- Lead Sponsor
- The Third Affiliated hospital of Zhejiang Chinese Medical University
- Brief Summary
Through the recruition of outpatients who clinically meet the diagnostic criteria and inclusion criteria of PI, the acupuncture group adopts Tiaoshen acupuncture, and the placebo acupuncture group adopts non-insertive acupuncture supported by the Park device, and the Pittsburgh Sleep Quality Index (PSQI) is used as the main index to evaluate the patients through the scale; subjective indicators like Chalder 14-item fatigue scale, Epworth sleepiness rating, self-rating anxiety scale (SAS), self-rating depression scale (SDS) and objective indicators like polysomnography (PSG), heart rate variability (HRV) is regarded as a secondary index, and then evaluate the clinical efficacy of Tiaoshen acupuncture on PI and explore its mechanism.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 84
- Conforming to the diagnostic criteria of traditional Chinese and Western medicine for chronic insomnia;
- Age range: 18-70 years old;
- PSQI score>7 points; SAS score > 50 or SDS score > 53;
- No communication and cognitive impairment;
- No use or withdrawal of psychoactive drugs such as anti-anxiety within one month; ·No major physical diseases;
- Those who voluntarily accept the research content and can complete various scale evaluations, polysomnography monitoring and HRV;
- Sign an informed consent form prior to the start of the study.
- Those who do not meet the inclusion criteria;
- Persons with a history of severe mental illness, severe head injury, and significant disturbance of consciousness;
- Those with severe liver and renal insufficiency and bleeding tendencies;
- Alcoholism (liquor ≥ 100ml/day), smoking (≥ 15 cigarettes/day), drug abuse or taking psychotropic drugs;
- People with other sleep disorders, such as sleep apnea hypopnea syndrome, paroxysmal sleeping sickness, and REM sleep behavioral disorders;
- Pregnant or nursing;
- Those with other major diseases and poor control;
- Other persons who are unwilling to sign informed consent.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description the acupuncture group the acupuncture group the patients included in this arm will recept the Tiaoshen acupuncture. the placebo acupuncture group the placebo acupuncture group Subjects in the placebo acupuncture group will receive non-insertive acupuncture using the sham needle supported by the Park device, and the selected acupoints is the same as the acupuncture group.
- Primary Outcome Measures
Name Time Method Pittsburgh sleep quality index 4 weeks after treatment Use the PSQI score table to evaluate according to patient's situation, and analyze the score changes of the subjects' insomnia degree before and after treatment by the analysis of score data.The PSQI consists of 19 self-rated questions and 5 questions rated by sleep partners. The 19 self-assessment questions constitute 7 factors ranging from 0 to 3 points. The cumulative score of each factor component is the total score of the PSQI, and the total score ranges from 0 to 21. The higher the score, the worse the sleep quality.
- Secondary Outcome Measures
Name Time Method Epworth Sleepiness Scale 4 weeks after treatment The epworth sleepiness scale is applied to assess excessive daytime sleepiness. The clinical significance of this table is: sleepiness can be semi-objectively assessed by the epworth sleepiness scale. Any sleep disorder caused by sleep deprivation may lead to change of this scale. This scale has 24 points. A score greater than 6 indicates drowsiness, a score greater than 11 indicates excessive sleepiness, and a score greater than 16 indicates dangerous drowsiness.
Fatigue Scale-14 4 weeks after treatment Respond to the severity of fatigue from different angles through 14 questions.The Fatigue Scale-14 is composed of 14 items, and the 14 items are divided into two categories. One category reflects physical fatigue, including 1 to 8 items; the other reflects mental fatigue, including 9 to 14 in total 6 items. The highest score for physical fatigue is 8, the highest score for mental fatigue is 6, and the highest total score is 14. The higher the score, the more severe the fatigue.
Self-Rating Anxiety Scale 4 weeks after treatment SAS is called anxiety self-rating scale, which is a standard for anxiety assessment and a psychological scale used to measure the degree of anxiety state and its changes during treatment. The SAS scale has 100 points in total, and the cut-off value is 50 points, of which 50-59 points are mild anxiety, 60-69 points are moderate anxiety, and more than 70 points are severe anxiety.
Polysomnography the 4th week of treatment Polysomnography refers to the continuous and synchronous acquisition, recording and analysis of EEG, electrooculogram, electromyogram, oronasal airflow, respiratory effort, and saturation of oxygen levels, body position and other physiological and pathological parameters during sleep by sleep technicians all night through computer software in the sleep laboratory. This technology for the diagnosis of sleep disorders is the gold standard for the diagnosis and treatment of sleep disorders.
Self-rating depression scale 4 weeks after treatment The depression self-rating scale is a standard for depression assessment, which can quite intuitively reflect the subjective feelings of depressed patients during treatment. It is mainly applicable to adults with depressive symptoms, including outpatients and inpatients. The SDS scale has 100 points in total, and the cut-off value is 53 points, of which 53-62 points are mild anxiety, 63-72 points are moderate anxiety, and more than 73 points are severe anxiety.
Heart rate variability the 4th week of treatment Heart rate variability (HRV) refers to the fluctuations in the interval between successive heartbeats. It is commonly used to evaluate the regulatory role of the autonomic nervous system on cardiac activity. It is an important noninvasive indicator for evaluating autonomic nervous activity, and is also one of the important indicators for evaluating autonomic nervous changes during sleep.
Trial Locations
- Locations (1)
The Third Affiliated Hospital of Zhejiang Chinese Medical University
🇨🇳Hangzhou, Zhejiang, China